BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29352142)

  • 1. FBXL10 contributes to the development of diffuse large B-cell lymphoma by epigenetically enhancing ERK1/2 signaling pathway.
    Zhao X; Wang X; Li Q; Chen W; Zhang N; Kong Y; Lv J; Cao L; Lin D; Wang X; Xu G; Wu X
    Cell Death Dis; 2018 Jan; 9(2):46. PubMed ID: 29352142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FBXL10/KDM2B scaffolding protein associates with novel polycomb repressive complex-1 to regulate adipogenesis.
    Inagaki T; Iwasaki S; Matsumura Y; Kawamura T; Tanaka T; Abe Y; Yamasaki A; Tsurutani Y; Yoshida A; Chikaoka Y; Nakamura K; Magoori K; Nakaki R; Osborne TF; Fukami K; Aburatani H; Kodama T; Sakai J
    J Biol Chem; 2015 Feb; 290(7):4163-77. PubMed ID: 25533466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.
    Wagner KW; Alam H; Dhar SS; Giri U; Li N; Wei Y; Giri D; Cascone T; Kim JH; Ye Y; Multani AS; Chan CH; Erez B; Saigal B; Chung J; Lin HK; Wu X; Hung MC; Heymach JV; Lee MG
    J Clin Invest; 2013 Dec; 123(12):5231-46. PubMed ID: 24200691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology, and the metabolome of fibroblasts.
    Janzer A; Stamm K; Becker A; Zimmer A; Buettner R; Kirfel J
    J Biol Chem; 2012 Sep; 287(37):30984-92. PubMed ID: 22825849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2.
    Ueda T; Nagamachi A; Takubo K; Yamasaki N; Matsui H; Kanai A; Nakata Y; Ikeda K; Konuma T; Oda H; Wolff L; Honda Z; Wu X; Helin K; Iwama A; Suda T; Inaba T; Honda H
    Blood; 2015 May; 125(22):3437-46. PubMed ID: 25872778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.
    Tzatsos A; Paskaleva P; Ferrari F; Deshpande V; Stoykova S; Contino G; Wong KK; Lan F; Trojer P; Park PJ; Bardeesy N
    J Clin Invest; 2013 Feb; 123(2):727-39. PubMed ID: 23321669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fbxl10/Kdm2b recruits polycomb repressive complex 1 to CpG islands and regulates H2A ubiquitylation.
    Wu X; Johansen JV; Helin K
    Mol Cell; 2013 Mar; 49(6):1134-46. PubMed ID: 23395003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.
    Farcas AM; Blackledge NP; Sudbery I; Long HK; McGouran JF; Rose NR; Lee S; Sims D; Cerase A; Sheahan TW; Koseki H; Brockdorff N; Ponting CP; Kessler BM; Klose RJ
    Elife; 2012 Dec; 1():e00205. PubMed ID: 23256043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of histone demethylase Fbxl10 leads to enhanced migration in mouse embryonic fibroblasts.
    Rohde M; Sievers E; Janzer A; Willmann D; Egert A; Schorle H; Schüle R; Kirfel J
    Exp Cell Res; 2016 Nov; 348(2):123-131. PubMed ID: 27646113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fbxl10/Kdm2b deficiency accelerates neural progenitor cell death and leads to exencephaly.
    Fukuda T; Tokunaga A; Sakamoto R; Yoshida N
    Mol Cell Neurosci; 2011 Mar; 46(3):614-24. PubMed ID: 21220025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells.
    Tzatsos A; Paskaleva P; Lymperi S; Contino G; Stoykova S; Chen Z; Wong KK; Bardeesy N
    J Biol Chem; 2011 Sep; 286(38):33061-9. PubMed ID: 21757686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer.
    Yan M; Yang X; Shen R; Wu C; Wang H; Ye Q; Yang P; Zhang L; Chen M; Wan B; Zhang Q; Xia S; Lu X; Shao G; Zhou X; Yu J; Shao Q
    Cell Death Dis; 2018 Nov; 9(11):1123. PubMed ID: 30409964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXL10 protects Polycomb-bound genes from hypermethylation.
    Boulard M; Edwards JR; Bestor TH
    Nat Genet; 2015 May; 47(5):479-85. PubMed ID: 25848754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic up-regulation of ribosome biogenesis and more aggressive phenotype triggered by the lack of the histone demethylase JHDM1B in mammary epithelial cells.
    Galbiati A; Penzo M; Bacalini MG; Onofrillo C; Guerrieri AN; Garagnani P; Franceschi C; Treré D; Montanaro L
    Oncotarget; 2017 Jun; 8(23):37091-37103. PubMed ID: 28415746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation.
    Han XR; Zha Z; Yuan HX; Feng X; Xia YK; Lei QY; Guan KL; Xiong Y
    Oncogene; 2016 Aug; 35(32):4179-90. PubMed ID: 26725323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis.
    Duan S; Moro L; Qu R; Simoneschi D; Cho H; Jiang S; Zhao H; Chang Q; de Stanchina E; Arbini AA; Pagano M
    Cell Rep; 2021 Oct; 37(3):109870. PubMed ID: 34686346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JMJD3 promotes survival of diffuse large B-cell lymphoma subtypes via distinct mechanisms.
    Zhang Y; Shen L; Stupack DG; Bai N; Xun J; Ren G; Han J; Li L; Luo Y; Xiang R; Tan X
    Oncotarget; 2016 May; 7(20):29387-99. PubMed ID: 27102442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXL10 promotes ERRα protein stability and proliferation of breast cancer cells by enhancing the mono-ubiquitylation of ERRα.
    Yang Y; Li S; Li B; Li Y; Xia K; Aman S; Yang Y; Ahmad B; Zhao B; Wu H
    Cancer Lett; 2021 Apr; 502():108-119. PubMed ID: 33450359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic study of the cellular metabolic regulation of Jhdm1b in tumor cells.
    Yu X; Wang J; Wu J; Shi Y
    Mol Biosyst; 2015 Jul; 11(7):1867-75. PubMed ID: 25877602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth.
    Bujisic B; De Gassart A; Tallant R; Demaria O; Zaffalon L; Chelbi S; Gilliet M; Bertoni F; Martinon F
    Blood; 2017 Apr; 129(17):2420-2428. PubMed ID: 28167662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.